Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

43.20
+0.66001.55%
Volume:108.61K
Turnover:4.64M
Market Cap:2.14B
PE:-23.34
High:43.31
Open:42.51
Low:41.99
Close:42.54
Loading ...
May 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 17, 2023

Major Issues Report

Form 8-K - Current report
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]